Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial
Carolina Porras, Sabrina H. Tsang, Rolando Herrero, Diego Guillén, Teresa M. Darragh, Mark H. Stoler, Allan Hildesheim, Sarah Wagner, Joseph F. Boland, Douglas R. Lowy, John T. Schiller, Mark Schiffman, John Schussler, Mitchell H. Gail, Wim Quint, Rebeca Ocampo, Jorge Morales, Ana Cecilia Rodríguez, Shangying Hu, Joshua N. Sampson, Aimée R. Kreimer, Bernal Cortés, Paula González, Rolando Herrero, Silvia E. Jiménez, Carolina Porras, Ana Cecilia Rodríguez, Allan Hildesheim, Aimée R. Kreimer, Douglas R. Lowy, Mark Schiffman, John T. Schiller, Mark E. Sherman, Lígia A. Pinto, Troy J. Kemp, Mary Sidawy, Wim Quint, Leen‐Jan van Doorn, Linda Struijk, Joel M. Palefsky, Teresa M. Darragh, Mark H. Stoler
Topics & Concepts
Bivalent (engine)MedicineVaccine efficacyVirologyVaccinationChemistryOrganic chemistryMetalCervical Cancer and HPV ResearchHead and Neck Cancer StudiesEndometrial and Cervical Cancer Treatments